118 related articles for article (PubMed ID: 33781907)
1. Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study.
Garcia Garrido HM; Knol MJ; Heijmans J; van Sorge NM; Sanders EAM; Klümpen HJ; Grobusch MP; Goorhuis A
Int J Infect Dis; 2021 May; 106():237-245. PubMed ID: 33781907
[TBL] [Abstract][Full Text] [Related]
2. Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study.
Andersen MA; Niemann CU; Rostgaard K; Dalby T; Sørrig R; Weinberger DM; Hjalgrim H; Harboe ZB
Clin Infect Dis; 2021 Feb; 72(3):463-471. PubMed ID: 32463435
[TBL] [Abstract][Full Text] [Related]
3. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R; Muller M; Powis J; Rau N; Walmsley S; Tyrrell G; Bitnun A; McGeer A;
Clin Infect Dis; 2016 Jan; 62(2):139-47. PubMed ID: 26354970
[TBL] [Abstract][Full Text] [Related]
4. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
5. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
6. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
Ciruela P; Izquierdo C; Broner S; Muñoz-Almagro C; Hernández S; Ardanuy C; Pallarés R; Domínguez A; Jané M;
Vaccine; 2018 Nov; 36(50):7744-7752. PubMed ID: 30473132
[TBL] [Abstract][Full Text] [Related]
7. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.
Picazo JJ; Ruiz-Contreras J; Casado-Flores J; Negreira S; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Amo MD; Méndez C;
Vaccine; 2019 Apr; 37(16):2200-2207. PubMed ID: 30902478
[TBL] [Abstract][Full Text] [Related]
8. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
[TBL] [Abstract][Full Text] [Related]
9. The impact of the changing pneumococcal national immunisation program among older Australians.
Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW
Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
[TBL] [Abstract][Full Text] [Related]
11. Trends in Invasive Pneumococcal Disease in Cancer Patients After the Introduction of 7-valent Pneumococcal Conjugate Vaccine: A 20-year Longitudinal Study at a Major Urban Cancer Center.
Lee YJ; Huang YT; Kim SJ; Kerpelev M; Gonzalez V; Kaltsas A; Papanicolaou G
Clin Infect Dis; 2018 Jan; 66(2):244-253. PubMed ID: 29020313
[TBL] [Abstract][Full Text] [Related]
12. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Baquero F; Hernández-Sampelayo T; Otheo E; Méndez C;
PLoS One; 2017; 12(2):e0172222. PubMed ID: 28207888
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Hypogammaglobulinemia in Adult Invasive Pneumococcal Disease.
Cowan J; Do TL; Desjardins S; Ramotar K; Corrales-Medina V; Cameron DW
Clin Infect Dis; 2018 Feb; 66(4):564-569. PubMed ID: 29401274
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
[TBL] [Abstract][Full Text] [Related]
15. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
16. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
Wei SH; Chiang CS; Chiu CH; Chou P; Lin TY
Pediatr Infect Dis J; 2015 Mar; 34(3):e71-7. PubMed ID: 25247584
[TBL] [Abstract][Full Text] [Related]
17. The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel.
Regev-Yochay G; Katzir M; Strahilevitz J; Rahav G; Finn T; Miron D; Maor Y; Chazan B; Schindler Y; Dagan R;
Vaccine; 2017 Apr; 35(18):2449-2456. PubMed ID: 28342668
[TBL] [Abstract][Full Text] [Related]
18. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
De Wals P; Lefebvre B; Deceuninck G; Longtin J
Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
[TBL] [Abstract][Full Text] [Related]
19. Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
Vaccine; 2018 May; 36(21):2985-2990. PubMed ID: 29685595
[TBL] [Abstract][Full Text] [Related]
20. Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland.
Lindström V; Aittoniemi J; Lyytikäinen O; Klemets P; Ollgren J; Silvennoinen R; Nuorti JP; Sinisalo M
Infect Dis (Lond); 2016; 48(5):399-402. PubMed ID: 26635103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
